• Jean-Philippe Pignol, Brian Keller, Eileen Rakovitch, Raxa Sankreacha, Harry Easton, and William Que.
• Department of Radiation Oncology, Sunnybrook and Women's Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Jean-Philippe.Pignol@sw.ca
• Int. J. Radiat. Oncol. Biol. Phys. 2006 Jan 1; 64 (1): 176-81.

PurposeA new technique of adjuvant partial breast irradiation using 103Pd permanent breast seed implants (PBSI) is presented. The procedure is performed in a single 1-hour session under local anesthesia.Methods And MaterialsPatients referred to a single institution for adjuvant radiotherapy after lumpectomy for an infiltrating ductal carcinoma < or = 3 cm in diameter, surgical margin > or = 2 mm, no extensive in situ carcinoma, no lymphovascular invasion, and minimal or negative lymph node involvement were offered a PBSI.ResultsBetween May and December 2004, 31 eligible patients underwent CT scan and ultrasound simulations assessing PBSI feasibility. Fifteen were excluded because of feasibility issues, and 16 received PBSI. A minimal peripheral dose of 90 Gy was prescribed to the planning target volume corresponding to the clinical target volume identified on the CT scan plus a margin of 1 cm. The procedure was well tolerated; 56% of the patients reported no pain during the procedure, and 46% of the patients developed National Cancer Institute Common Toxicity Criteria Grade 1 acute reaction. None experienced toxicity Grade 2 or 3.ConclusionsPermanent breast seed implantation seems feasible and well tolerated on these preliminary clinical data and represents an ultimate step in the reduction of treatment fraction for partial breast irradiation.

23 keywords...

hide…